These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. Locatelli F, Carbarns IR, Maschio G, Mann JF, Ponticelli C, Ritz E, Alberti D, Motolese M, Janin G, Zucchelli P. Kidney Int Suppl; 1997 Dec; 63():S63-6. PubMed ID: 9407424 [Abstract] [Full Text] [Related]
4. Cost-effectiveness of pharmacogenetic testing to predict treatment response to angiotensin-converting enzyme inhibitor. Costa-Scharplatz M, van Asselt AD, Bachmann LM, Kessels AG, Severens JL. Pharmacogenet Genomics; 2007 May; 17(5):359-68. PubMed ID: 17429318 [Abstract] [Full Text] [Related]
8. Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism. Vegter S, Perna A, Hiddema W, Ruggenenti P, Remuzzi G, Navis G, Postma MJ. Pharmacogenet Genomics; 2009 Sep; 19(9):695-703. PubMed ID: 19696696 [Abstract] [Full Text] [Related]
9. To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy. Clark WF, Churchill DN, Forwell L, Macdonald G, Foster S. CMAJ; 2000 Jan 25; 162(2):195-8. PubMed ID: 10674051 [Abstract] [Full Text] [Related]
10. Benazepril: a new ACE inhibitor. Bell J. ANNA J; 1993 Apr 25; 20(2):187-8. PubMed ID: 8512378 [Abstract] [Full Text] [Related]
11. Economic evaluation of sevelamer in patients with end-stage renal disease. Manns B, Klarenbach S, Lee H, Culleton B, Shrive F, Tonelli M. Nephrol Dial Transplant; 2007 Oct 25; 22(10):2867-78. PubMed ID: 17595182 [Abstract] [Full Text] [Related]
12. [Can angiotensin-converting enzyme inhibitor be used in chronic kidney disease patients with serum creatinine level greater than 266 micromol/L?]. Zhang GH, Hou FF, Zhang X, Liu QF. Zhonghua Nei Ke Za Zhi; 2005 Aug 25; 44(8):592-6. PubMed ID: 16194413 [Abstract] [Full Text] [Related]
15. Treatment of IgA nephropathy with angiotensin converting enzyme inhibitors: design of a prospective randomized multicenter trial. Coppo R, Chiesa M, Peruzzi L, Amore A. J Nephrol; 2001 Aug 25; 14(6):447-52. PubMed ID: 11783600 [Abstract] [Full Text] [Related]
16. Effect of benazepril in chronic renal insufficiency. Curren CG. N Engl J Med; 1996 Aug 22; 335(8):597; author reply 597. PubMed ID: 8684418 [No Abstract] [Full Text] [Related]
17. Effect of benazepril in chronic renal insufficiency. Apperloo AJ, Rensma PL. N Engl J Med; 1996 Aug 22; 335(8):596-7; author reply 597. PubMed ID: 8684417 [No Abstract] [Full Text] [Related]
19. [Use of angiotensin-converting enzyme inhibitors in chronic kidney insufficiency]. Kutyrina IM, Lifshits NL, Rogov VA, Kamyshova ES, Shvetsov MIu, Okonova EB, Androsova SO, Martynov SA, Miroshnichenko NG, Gerasimenko OI. Ter Arkh; 2002 Aug 22; 74(6):34-9. PubMed ID: 12136480 [Abstract] [Full Text] [Related]
20. Evaluation of the clinical efficacy of benazepril in the treatment of chronic renal insufficiency in cats. Mizutani H, Koyama H, Watanabe T, Kitagawa H, Nakano M, Kajiwara K, King JN. J Vet Intern Med; 2006 Aug 22; 20(5):1074-9. PubMed ID: 17063698 [Abstract] [Full Text] [Related] Page: [Next] [New Search]